These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Determination of estrogen and progesterone receptors in epithelioma of the uterine cervix. (Apropos of a series of 101 cases)]. Fenton J; Asselain B; Magdelenat H Bull Cancer; 1986; 73(2):124-6. PubMed ID: 3730632 [No Abstract] [Full Text] [Related]
8. [Estrogen and progesterone receptor assay in the normal endometrium and endometrial carcinoma]. Li SY Zhonghua Zhong Liu Za Zhi; 1984 Nov; 6(6):429-31. PubMed ID: 6532745 [No Abstract] [Full Text] [Related]
9. [Correlation of the biochemical and histochemical determination of hormone receptors in carcinoma of the breast with the age of the patient, stage and histologic type of the neoplasm]. Campobasso O; Concina S; Cozzani C; Ribotta M; Di Carlo F; Conti G; Racca S Pathologica; 1987; 79(1059-1060):53-9. PubMed ID: 3441412 [No Abstract] [Full Text] [Related]
10. [Inflammatory breast cancers: correlation between anatomopathology and steroid receptor assay]. Mauriac L; Wafflart J; Trojani M; Durand M Bull Cancer; 1983; 70(3):160-4. PubMed ID: 6309290 [TBL] [Abstract][Full Text] [Related]
11. [Progress on pathological study of ovarian epithelial tumors]. Tang SE Zhonghua Fu Chan Ke Za Zhi; 1993 Apr; 28(4):194-7. PubMed ID: 8404298 [No Abstract] [Full Text] [Related]
12. Clinical correlation of hormone receptor status in epithelial ovarian cancer. Masood S; Heitmann J; Nuss RC; Benrubi GI Gynecol Oncol; 1989 Jul; 34(1):57-60. PubMed ID: 2737527 [TBL] [Abstract][Full Text] [Related]
13. [Steroid receptor status as prognostic factor in ovarian cancer]. Schieder K; Biegelmayer C; Kölbl H; Breitenecker G Gynakol Rundsch; 1990; 30 Suppl 1():65-7. PubMed ID: 2079302 [No Abstract] [Full Text] [Related]
14. Estrogen and progestin receptors in an ovarian ependymoma. Auerbach R; Mittal K; Schwartz PE Obstet Gynecol; 1988 Jun; 71(6 Pt 2):1043-5. PubMed ID: 2836769 [TBL] [Abstract][Full Text] [Related]
15. Steroid hormone receptors and flow cytometric DNA ploidy in ovarian carcinoma. Grénman SE; Klemi P; Toikkanen S; Kaihola HL; Laippala P; Mäenpää J; Mäkinen J; Grönroos M Ann Chir Gynaecol Suppl; 1994; 208():15-9. PubMed ID: 8092763 [TBL] [Abstract][Full Text] [Related]
16. Histopathologic correlations of estrogen and progestin receptor protein in epithelial ovarian carcinomas. Schwartz PE; Merino MJ; Livolsi VA; Lawrence R; MacLusky N; Eisenfeld A Obstet Gynecol; 1985 Sep; 66(3):428-33. PubMed ID: 4022502 [TBL] [Abstract][Full Text] [Related]
17. [Cytosol receptor levels in malignant and benign ovarian tumors]. Thurzó L; Falkay G; Sas M Orv Hetil; 1987 Aug; 128(36):1881-4, 1887. PubMed ID: 3658406 [No Abstract] [Full Text] [Related]
18. [Correlation between estrogen and progestin receptor protein and histopathology in ovarian tumor]. Wang JH; Han SW; Cao ZY; Wang SL; Sun WG Hua Xi Yi Ke Da Xue Xue Bao; 1988 Sep; 19(3):301-4. PubMed ID: 3253178 [No Abstract] [Full Text] [Related]
20. The expression analysis of the estrogen and progesterone receptors in endometrial carcinomas. Olech-Fudali E; Chibowski D; Skomra D; Walczyna B Ann Univ Mariae Curie Sklodowska Med; 2001; 56():319-25. PubMed ID: 11977333 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]